BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14563956)

  • 1. Antithrombotic therapy after cerebral hemorrhages.
    Stöllberger C; Finsterer J
    Stroke; 2003 Nov; 34(11):e217-8; author reply e217-8. PubMed ID: 14563956
    [No Abstract]   [Full Text] [Related]  

  • 2. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis.
    Eckman MH; Rosand J; Knudsen KA; Singer DE; Greenberg SM
    Stroke; 2003 Jul; 34(7):1710-6. PubMed ID: 12805495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding.
    Ghattas A; Shantsila E; Lip GY
    Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):5-9. PubMed ID: 21282200
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratification.
    Patti G; Di Sciascio G
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):128-34. PubMed ID: 19670304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications of anticoagulant and thrombolytic therapy].
    Sparacia A; Di Chiara A
    Minerva Anestesiol; 1981 Mar; 47(3):115-22. PubMed ID: 6454086
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemorrhagic neurologic complications during therapy with anticoagulants and fibrinolytic agents].
    Bewermeyer H; Schumacher A; Neveling M; Heiss WD
    Dtsch Med Wochenschr; 1984 Oct; 109(43):1653-9. PubMed ID: 6386418
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant and defibrinogenating agents in acute ischemic stroke and cerebral venous thrombosis.
    Meschia JF
    Semin Neurol; 1998; 18(4):461-70. PubMed ID: 9932617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural management of antithrombotic therapy in hospitalized patients.
    Feinbloom D
    J Hosp Med; 2014 May; 9(5):337-46. PubMed ID: 24550198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral microbleeds on T2*-weighted images and hemorrhagic transformation after antithrombotic therapies for ischemic stroke.
    Takahashi W; Moriya Y; Mizuma A; Uesugi T; Ohnuki Y; Takizawa S
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e528-32. PubMed ID: 23830955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations.
    Schneble HM; Soumare A; Hervé D; Bresson D; Guichard JP; Riant F; Tournier-Lasserve E; Tzourio C; Chabriat H; Stapf C
    Stroke; 2012 Dec; 43(12):3196-9. PubMed ID: 23150651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation.
    Singh PP; Singh M; Bedi U; Molnar J; Arora R; Khosla S
    Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):23-31. PubMed ID: 21183532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral Hemorrhage and Exposure to Antithrombotic Drugs.
    Nielsen PB; Milling TJ; Lip GYH
    JAMA Netw Open; 2021 May; 4(5):e219175. PubMed ID: 33950212
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying the stroke victim at risk for hemorrhage during thrombolysis.
    SoRelle R
    Circulation; 2002 Apr; 105(14):e9094-5. PubMed ID: 11940564
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complications of anticoagulant and thrombolytic treatment].
    Auzépy P; Nitenberg G; Ricome JL
    Rev Prat; 1977 Dec; 27(57):4021-34. PubMed ID: 345402
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents.
    Perry JR
    Curr Opin Neurol; 2010 Dec; 23(6):592-6. PubMed ID: 20881488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic agents and invasive procedures--hematologist point of view.
    Lecompte TP
    Thromb Res; 2012 Oct; 130 Suppl 1():S61-2. PubMed ID: 23026666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
    Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
    J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy.
    Gathier CS; Algra A; Rinkel GJ; van der Worp HB
    Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study.
    Toyoda K; Yasaka M; Iwade K; Nagata K; Koretsune Y; Sakamoto T; Uchiyama S; Gotoh J; Nagao T; Yamamoto M; Takahashi JC; Minematsu K;
    Stroke; 2008 Jun; 39(6):1740-5. PubMed ID: 18388341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Janus face of thromboprophylaxis in patients with high risk for both thrombosis and bleeding during intracranial surgery: report of five exemplary cases.
    Niemi T; Silvasti-Lundell M; Armstrong E; Hernesniemi J
    Acta Neurochir (Wien); 2009 Oct; 151(10):1289-94. PubMed ID: 19513580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.